<div id="readability-page-1"><div>Zoetis Inc. (ZTS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationLaw Offices of Howard G. Smith announces an investigation on behalf of Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS) investors concerning the Company’s possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ZOETIS INC. (ZTS), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@howardsmithlaw.com, by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.What Happened?On May 7, 2026, Zoetis reported financial results for the first quarter of 2026. Among other items, Zoetis reported net income of $601 million, flat year over year, and cuts to its full year 2026 profit guidance to between $6.85 and $7 a share, down from prior guidance of $7.00 to $7.10 a share. CEO Kristin Peck said in the earnings release “the first quarter unfolded in a more challenging operating environment than we anticipated. Pet owners demonstrated increased price sensitivity, resulting in a decline in veterinary visits and softer demand[.]”On this news, the price of Zoetis shares declined by $23.91 per share, or 21.50%, to close at $87.31 on May 7, 2026.Contact Us To Participate or Learn More: If you purchased Zoetis securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, Telephone: (215) 638-4847 Email: howardsmith@howardsmithlaw.com, Visit our website at: www.howardsmithlaw.com.This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. <img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1tc3RyMyZzdHk9MjAyNjA1MTg3NTgzMjhyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1tc3RyMyZzdHk9MjAyNjA1MTg3NTgzMjhyMQ"/>Law Offices of Howard G. Smith Howard G. Smith, Esquire 215-638-4847 howardsmith@howardsmithlaw.com www.howardsmithlaw.comView source version on businesswire.com: https://www.businesswire.com/news/home/20260518758328/en/</div></div>

硕腾

生物科技 ETF - VanEck Vectors

标普生物技术 3 倍做多 - Direxion

霍华德·G·史密斯律师事务所正在调查与硕腾（Zoetis Inc.，股票代码：ZTS）相关的潜在证券欺诈行为，此前该公司报告 2026 年第一季度净收入持平，为 6.01 亿美元，并下调了盈利指引。消息公布后，硕腾的股价下跌了 21.50%，至 87.31 美元。遭受损失的股东被鼓励联系该律师事务所以寻求潜在索赔

Zoetis Inc. (ZTS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

MorningStar

标普生物技术 ETF - SPDR

医药突破 ETF - ALPS

医疗业 ETF - Vanguard

纳斯达克生物科技指数 ETF - iShares Nasdaq

基因改革 ETF - ARK

纽交所高增长板生物技术指数 ETF - First Trust

2 倍做多纳斯达克生物技术 ETF - ProShares

Invesco Nasdaq Biotechnology ETF

动态生物技术与基因组 ETF - Invesco

美国制药 ETF - iShares

医疗业 ETF - SPDR

硕腾公司 (ZTS) 的股东若遭受损失，请联系霍华德·G·史密斯律师事务所以了解证券欺诈调查